Industry Reports

While the regenerative medicine spectrum continues its upward trend, artificial intelligence incorporation happens to be playing a role that’s especially transformative in the pharmaceutical sector. The fact is that AI-driven drug discovery can go on to evaluate chemical compounds...

Across the past so many years, there have been pharmaceutical companies that have been integrating artificial intelligence steadily into many elements of clinical development. The effect that artificial intelligence has today is indeed being felt right from the bench...

The worldwide active pharmaceutical ingredient market size happened to be valued at $214.72 billion in 2023 and is all set to reach a $384 billion valuation by 2033 with a CAR of 6.08% right from 2024 to 2033. Integration when...

A Business Research Company report goes on to predict that the small-molecule injectable drug market is going to be valued at approximately $355 billion in 2028. The CAGR is anticipated to be almost 13% up to the said year. Elements...

AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and by launching...

As per new market research that’s titled 'Bioinformatics Market Size, Share, Forecast, & Trends Analysis by Solutions & Services (Knowledge Management, Sequence Analysis, Data Analysis) Application (Genomics, Metabolomics, Transcriptomics) Industry (Health, Agriculture) – Global Forecast to 2031, the bioinformatics...

Pharmaceutical companies are turning their attention to the Indian market as revenues decline in the US, Europe, and emerging markets. Indian companies like Sun Pharma, Dr. Reddy's, and Cipla are eyeing the domestic market for solid revenues. The Indian...